CARLSBAD, Calif., April 01, 2024 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development. Dr. Hubbert has an extensive background in cell therapy research and venture investment across a broad range of therapeutic modalities and development stages, and has a
African Centers of Excellence in Bioinformatics and Data-Intensive Science 2022 Annual Consortium Meeting – Student Showcase | September 13, 2022 usembassy.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usembassy.gov Daily Mail and Mail on Sunday newspapers.